Clinicopathological markers associated with recurrence in ductal carcinoma in situ of breast by age group

참고문헌 (Reference)

1 한원식, "한국인 유방 관상피내암의 재발에 영향을 미치는 임상병리학적 특성과 인자" 한국유방암학회 13 (13): 392-397, 2010

2 Son BH, "The recurrence rate, risk factors and recurrence patterns after surgery in 3700 patients with operable breast cancer" 9 : 134-144, 2006

3 Sanders ME, "The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up" 103 : 2481-2484, 2005

4 Bijker N, "Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853" 19 : 2263-2271, 2001

5 Carter CL, "Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases" 63 : 181-187, 1989

6 Allred DC, "Prognostic and predictive factors in breast cancer by immunohistochemical analysis" 11 : 155-168, 1998

7 Allegra CJ, "National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009" 102 : 161-169, 2010

8 Zhou W, "Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study" 13 : 512-, 2013

9 Williams KE, "Molecular phenotypes of DCIS predict overall and invasive recurrence" 26 : 1019-1025, 2015

10 Korean Statistical Information Service, "Incidence and the number of cancer by sex in 2015 [Internet]" Korean Statistical Information Service

11 Statistics Korea, "Incidence and mortality of cancer from 2000 to 2015; c2015 [Internet]" Statistics Korea

12 Chasle J, "Immunohistochemical study of cell cycle regulatory proteins in intraductal breast carcinomas: a preliminary study" 39 : 1363-1369, 2003

13 Roka S, "High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS" 30 : 243-247, 2004

14 Vargas AC, "Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression" 135 : 153-165, 2012

15 Ma XJ, "Gene expression profiling of the tumor microenvironment during breast cancer progression" 11 : R7-, 2009

16 Burkhardt L, "Gene amplification in ductal carcinoma in situ of the breast" 123 : 757-765, 2010

17 Virnig BA, "Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes" 102 : 170-178, 2010

18 Hu M, "Distinct epigenetic changes in the stromal cells of breast cancers" 37 : 899-905, 2005

19 Ko SS, "Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996-2006) using nationwide breast cancer registration on-line program: biannual update" 98 : 318-323, 2008

20 Kerlikowske K, "Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis" 102 : 627-637, 2010

21 Frykberg ER, "An overview of the history and epidemiology of ductal carcinoma in situ of the breast" 3 : 227-231, 1997

22 Vicini FA, "Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature" 20 : 2736-2744, 2002

23 Barnes NL, "Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast" 11 : 2163-2168, 2005